Tonia Bargmann

Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma.

Yuran Xie, O. Merkel, Aditi Mehta, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology.

V. Satagopam, K. Sewald, V. Neuhaus, 2024, Clinical immunology.